Rating

	My Rating: 1 ratings 5 stars (1) 4 stars (0) 3 stars (0) 2 stars (0) 1 stars (0)

Email

	Email this page to a friend Friend's Email: Your Name: Your Email: Enter the code shown: Submitting Send Email

References

1. Prusinsky A. Possibility of timolol use for immediate alleviation of Horton’s cluster headache. Preliminary report. Neurologia I Neurochirurgia Polska 1980;14(2):191-193 
    
2. Shapiro MK, Gorn R. The possible treatment of migraine with carteolol hydrochloride. Headache 1999(2):138-139
    
3. Ishikawa H, Yoshihara M, Mizuki K, Kashima Y. A pediatric case of ophthalmoplegic migraine with recurrent oculomotor nerve palsy. Jpn J Ophthalmol 2000;44(5)576
    
4. Bhagey J, James B. Topical timolol prevented migraine attacks. Eye 2004;18(7)751
    
5. Chiam PJT. Topical beta blocker treatment for migraine. Int Ophthalmol 2012;32:85-88
    
6. Diener HCh. Pharmacological approaches to migraine. J Neural Transm Suppl 2003(64)35-63
    
7. Shamliyan TA, Kane RL, Taylor FR. Migraine in adults: Preventive pharmacologic treatments. Agency for Healthcare Research and Quality (US); 2013 Apr. Report No.: 13-EHC068-EF. http://www.ncbi.nlm.nih.gov/pubmed/23700633
    
8. Rahimtoola H, Buurma H, Tijssen CC, Leufkens HG, Egberts AC. Incidence and determanents of migraine prophylactic medication in the Netherlands. Eur J Clin Pharmacol 2002;58(2)149-55
    
9. Zimmerman TJ, Kaufman HD. Timolol. A Beta-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol 1977;95(4);601-604
    
10. Banerjee M, Findley L. Propranolol in the treatment of acute migraine attacks. Cephalalgia 11(4):193-196, 1991 Sept
     
11. Fuller, GN, Guiloff, RJ. Propranolol in acute migraine: a controlled study. Cephalalgia.  10(5):229-233, 1990 Oct
     
12. Nieminen T, Lehtimaki T, Maenpaa J, Ropo A, Uusitalo H, Kahonen. Ophthalmic timolol: Plasma concentration and systemic cardiopulmonary effects. Scand j Clin Lab Invest 2007;67:237-245
     
13. Yoshiyuki, O, Yasuhiko, Y, Miyuki, N, Makoto, A, Risa, T. Pharmacokinectic and Pharmacodynamic Analysis of Systemic Effect of Topically Applied Timolol Maleate Ophthalmic Gelling Vehicle. Curr Eye Res 30:319-328, 2005
     
14. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682043.html#precautions
     
15. http://eurheartjsupp.oxfordjournals.org/content/11/suppl_A/A21.full
     
16. Pond SM, Tozer TN. First-pass elimination. Basic concepts and clinical consequences. Clin Pharmacokinet 1984;1:1-25
     

Disclosure

None reported.

Acknowledgment

We wish to thank Charles M. Lederer, MD, for review and useful suggestions and Evelyn Vail, medical librarian for her help with the literature search.

Continued on next page >